| Listed site | cro | cro |
|---|
| Summary | Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities. | Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities. |
|---|
| Services | - Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Specialized & Large-Animal Models
- GLP Toxicology
- Biomarker Assays
- Flow Cytometry Services
- Bioanalysis
- Bioinformatics & Data Science
- Genomics & Sequencing Services
- Proteomics Services
- Pathology & Histology Services
- Translational Research
- Oncology Specialty Services
- Immunology & Inflammation Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
| - High-Throughput Screening
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- GLP Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Discovery Research
- Specialized & Large-Animal Models
- Oncology Specialty Services
- Immunology & Inflammation Services
- Target Identification & Validation
- Genetic Toxicology
- Immunogenicity Assays (ADA / NAb)
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- mRNA
- Peptide
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
|
|---|
| Indications | - Oncology
- Immunology
- Neurology
- Nephrology
- Metabolic
- Cardiovascular
| - Oncology
- Immunology
- Infectious Disease
|
|---|
| Locations | Data not yet provided. | - Global Headquarters, Malvern, PA, USA
- Hershey, Hershey, PA, USA
- Freiburg, Freiburg, Freiburg, Germany
- Heidelberg, Heidelberg, Heidelberg, Germany
- Research Facility, Hershey, PA, USA
- Research Facility, Freiburg, Freiburg, Germany
- Research Facility, Heidelberg, Heidelberg, Germany
|
|---|
| Certifications | Data not yet provided. | - ISO · Identifier: ISO 9001:2015
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|